RESOLVING THE LEDGER
RESOLVING THE LEDGER
This is not a single article. It's every outletcovering this one event, gathered in one place — read AIPROPX's summary, see where the sources line up, then open any report at its origin.
By AIPROPX Editorial Desk · Published · Updated
Everything reported about this story, gathered from 5 sources. Read the summary below, then tap any source to open that report.
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Summary indexed by AIPROPX from CNBC’s reporting — the full article is one click away. Open at source →
5 outlets are covering this. Resolve the ledger to read what they collectively report — the common thread, in plain terms.
Every report on this story — read the summary of each, then open any at its source. AIPROPX summarizes and links; it never reproduces the original.
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Read this reportThe vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Read this report
The mRNA-based vaccine combined with Keytruda reduced melanoma recurrence in more than 1,100 patients whose cancer had been surgically removed
Read this report
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology.
Read this reportAn original, deterministic readout — composed only from the computed coverage facts on this page. No interpretation, no rating; figures only.
AIPROPX has consolidated 6 reports from 5 outlets into a single canonical entry on “Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%.” The covered outlets are based across 2 regions — US and Other.
The earliest report in this entry came from STAT (Aug 19, 2026, 10:45 UTC); the most recent came from CNBC (Aug 19, 2026, 12:54 UTC).
Comparing the wording across sources, 3 named entities are referenced by multiple outlets and the phrase recurring most across the coverage is “cancer vaccine”.
5 statements are carried by only one outlet within this set and are not echoed by the others.
Every figure above is a direct count of real published articles. AIPROPX indexes and compares the original reporting — it never rewrites, rates, or editorializes — and each publisher’s full article is always one click away.
Generated by AIPROPX from the source counts above. AIPROPX indexes and resolves coverage; the original publishers are credited and linked at origin in every report.
Coverage from 5 independent outlets across 2 regions — each view opens on its own page.
AIPROPX — “Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%” · https://www.aipropx.com/story/d7ab9e876fe3d0a7bfb362e8cb2ce497
Other events being covered across multiple sources right now.
Chinese Robot Maker Unitree Soars 500 Percent in Trading Debut
7 outletsStock market today: Dow, S&P 500, Nasdaq futures stall after Trump pauses tariffs on Canada
6 outletsMinnesota attorney general sues Texas governor to compel extradition of ICE agent for trial
3 outletsCamilla admits it was 'difficult' to keep King's cancer diagnosis a secret. #BBCNews
4 outletsTupac Shakur Murder Trial: Gunfire Erupts Near Courthouse
4 outletsRibbon cutting set for Promise Heights, new housing for families in Lawrence